SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-023996
Filing Date
2024-09-26
Accepted
2024-09-26 16:36:21
Documents
2
Period of Report
2024-09-17

Document Format Files

Seq Description Document Type Size
1 form3-09262024_080918.html 3  
1 form3-09262024_080918.xml 3 3289
2 ex24-09262024_080922.htm EX-24 6087
  Complete submission text file 0001415889-24-023996.txt   10829
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SENSEI BIOTHERAPEUTICS, INC. 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address
Craver Josiah (Reporting) CIK: 0002038400 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39980 | Film No.: 241329476